Position in LLY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$7,952,221
+$1,784,244 QoQ
Shares Held
6,630
-1.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.99%
of 13F equity value
Holder Rank
#1,389
of 4,605 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ayrshire Capital Management LLC holds $9,068,388 across 4 Drug Manufacturers - General names. LLY ranks #1 (87.7% of the industry book) .
All Filings in LLY
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,952,221 | 6,630 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $6,167,977 | 6,706 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $10,371,737 | 9,651 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $7,420,938 | 9,726 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $6,697,721 | 8,592 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $6,464,397 | 7,827 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $5,930,504 | 7,682 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $6,578,990 | 7,426 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $6,060,613 | 6,694 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $5,153,985 | 6,625 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $3,617,018 | 6,205 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $3,188,403 | 5,936 | Shares | Sole | 2023-10-12 | |
| No filing history on record for this holder in this stock. | ||||||